- The Bleeding Risk during Warfarin Therapy Is Associated with the Number of Variant Alleles of CYP2C9 and VKORC1 Genes2013 | 1. lékařská fakulta, Fakulta tělesné výchovy a sportu, Lékařská fakulta v Plzni, 2. lékařská fakulta
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease2017 | 3. lékařská fakulta
- Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)2019 | Lékařská fakulta v Plzni
- Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome2011 | Publikace bez příslušnosti k fakultě
- Antikoagulační léčba v sekundární prevenci koronárních příhod2014 | 3. lékařská fakulta
- Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatrantreated patients: a series of 11 cases2017 | Lékařská fakulta v Hradci Králové
- Targeting out-of-hospital cardiac arrest: The effect of heparin administered during cardiopulmonary resuscitation (T-ARREST)2011 | 3. lékařská fakulta, Lékařská fakulta v Hradci Králové
- P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries2016 | 3. lékařská fakulta
- Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation2017 | Publikace bez příslušnosti k fakultě
- Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolismPublikace bez příslušnosti k fakultě
- Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation Registries2021 | Lékařská fakulta v Plzni
- Prevence a léčba kardiovaskulárních a krvácivých komplikací u nemocných s chronickou lymfocytární leukemií léčených inhibitory Brutonovy kinázy2023 | Lékařská fakulta v Hradci Králové, 1. lékařská fakulta
- Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin2014 | Publikace bez příslušnosti k fakultě
- Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome2015 | Publikace bez příslušnosti k fakultě
- Inferiority of ticagrelor in the PHILO trial: Play of chance in East Asians or nightmare confirmation of PLATO-USA?2016 | 2. lékařská fakulta
- Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes2017 | 3. lékařská fakulta
- Blunting periprocedural myocardial necrosis: Rationale and design of the randomized ALPHEUS study2020 | 3. lékařská fakulta
- Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children2020 | 2. lékařská fakulta